Imperial Laboratories

Imperial Laboratories Imperial Genetics provides an extensive portfolio of prenatal, reproductive, neonatal, postnatal, and oncology tests, as well as clinical laboratory tests.


In the event of miscarriage, it is important to determine the causes.Miscarriages in the first trimester of pregnancy happen relatively often. One in every t...



What is NACE test?NACE is a non-invasive prenatal test. This means that it is completely safe for you and your baby: a small blood sample, just like in any o...

Genetic testing consists of examining the DNA for any changes that may affect your health. The test itself is a simple blood draw, but interpreting those res...



Evartia is a genetic test that screens for genetic changes associated with inherited metabolic diseases in 223 genes. Symptoms of inherited metabolic diseases can manifest shortly after birth or at infancy, childhood, adolescence or adulthood.

With Evartia, early detection has a higher potential to reduce symptoms or minimize their severity, improving the quality of life of the person with the metabolic disease.

For more info about Evartia and how it can help you, visit:


Results from Whole Exome Sequencing (WES) analysis could guide you to reach a diagnosis sooner, avoiding extensive, costly and lengthy serial testing.

NIPD Genetics WES analysis is an advanced genetic test that looks at the genetic information of approximately 20,000 genes in a single test.
Discuss with your doctor if WES analysis is right for you.

👉For more info visit:


When detected early, the conditions tested in Oreana Neonatal Screening can be manageable or treatable given how therapies and clinical management can prevent serious, life-long consequences including developmental delay and premature death, benefiting the prognosis and the quality of life of the affected child.

👉Further info about the expanded Oreana Neonatal Screening can be found here:


When it comes to your baby’s health, you don’t want to be surprised

VERAgene is the only comprehensive NIPT test that can simultaneously screen for common aneuploidies, selected clinically significant microdeletions and a panel of 100 single gene (monogenic) diseases, like β-thalassemia, cystic fibrosis and phenylketonuria, as early as the 10th week of pregnancy.

Talk to your doctor to learn more about whether VERAgene comprehensive NIPT is right for you.

For more info visit:


July is Sarcoma Awareness month!

Sarcomas are uncommon cancers that can occur in various locations of the body. Early detection is important to increase the chances of successful treatment.
Li-Fraumeni syndrome (LFS) that is included in the PreSENTIA hereditary cancer test panels, is an inherited familial predisposition cancer syndrome that is associated with an increased risk of sarcomas, among other cancers.

For more information, please visit:


When can NeoThetis liquid biopsy test be performed?

NeoThetis can be performed at diagnosis for therapy selection, or during disease progression, when the patient has acquired resistance to previous treatment, for therapy re-evaluation.

For more information about Neo Thetis:


NIPD Genetics’ innovative genetic testing services in Reproductive Health helps clinicians provide their patients with robust, reliable and time-sensitive solutions at the preconception, preimplantation and prenatal phases of their reproductive journey.

To learn more about our comprehensive reproductive health portfolio of genetic testing services and laboratory solutions visit:


It’s International PKU Awareness Day!

Phenylketonuria (PKU) is an inherited, autosomal recessive condition. Treatment of PKU consists of maintaining phenylalanine levels within normal range through a controlled, specialized diet that must be followed throughout the patient’s life, otherwise symptoms can appear.

VERAgene comprehensive , offered by NIPD Genetics a Medicover Company, can detect PKU, along with 99 other monogenic diseases, aneuploidies and microdeletions from the 10th week of pregnancy.

To learn more about PKU, read our blog post at


It's Global Rare Chromosome Disorder Awareness Week!

A week to educate and shine a light on the individuals and families affected by rare chromosome disorders and celebrate all the unique children and adults.

Learn more about chromosomes and rare disorders at


Today is

The otherwise known as 4p- syndrome is a rare genetic disorder caused by a missing piece of genetic material on chromosome 4, which usually results in characteristic facial features, seizures, and various physical disabilities.

Children with 4p- syndrome are usually born with low birth weight and develop slowly, both cognitively and physically, compared to their same-age peers, and experience medical complications while maintaining strong social skills.

Wolf-Hirschhorn Syndrome is screened by both our prenatal tests, VERACITY NIPT and VERAgene Comprehensive NIPT, for early detection.

Learn more about VERACITY and VERAgene NIPTs at


With VERACITY new generation NIPT you can get valuable insights into your baby’s health as early as 10 weeks into your pregnancy. VERACITY is validated in three multi-center studies using thousands of samples and it is used by health professionals around the world. Ask your doctor about VERACITY today. You can also visit to learn more about all the conditions screened by VERACITY.

For more details contact us:


Office No3, First Floor, Malak Plaza, Block 16c, F8 Markaz


Be the first to know and let us send you an email when Imperial Laboratories posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Imperial Laboratories:



Nearby clinics